🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Inflammatory Bowel Disease Registry in Daegu-Gyeongbuk

Recruitingn/aAges any - anyAllKyungpook National University Hospital
NCT02193464 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to investigate the incidence and natural course of inflammatory bowel disease in the southeastern area of Korea.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Clinical diagnosis of inflammatory bowel disease including Crohn's disease and ulcerative colitis * Followed up for at least 6 months for the correct diagnosis Exclusion Criteria: * Patients who do not live in Daegu-Gyeongbuk province
💊

What it tests

  • Not listed
📍

Where

1 site
Keimyung University Dongsan Medical Center
Daegu, South Korea
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy